110 related articles for article (PubMed ID: 19100646)
21. [Wilms tumor as a novel model of angiogenesis in childood nephropathies].
Nowicki M; Ostalska-Nowicka D; Zachwieja J; Lewandowska L; Kaczmarek-Kanold M; Miśkowiak B
Przegl Lek; 2006; 63 Suppl 3():87-9. PubMed ID: 16898498
[TBL] [Abstract][Full Text] [Related]
22. Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
Eskens FA; Steeghs N; Verweij J; Bloem JL; Christensen O; van Doorn L; Ouwerkerk J; de Jonge MJ; Nortier JW; Kraetzschmar J; Rajagopalan P; Gelderblom H
J Clin Oncol; 2009 Sep; 27(25):4169-76. PubMed ID: 19636022
[TBL] [Abstract][Full Text] [Related]
23. Bilateral surgical resection in pulmonary epitheloid hemangioendothelioma.
Schattenberg T; Pfannschmidt J; Herpel E; Schnabel PA; Mechtersheimer G; Dienemann H
Thorac Cardiovasc Surg; 2007 Apr; 55(3):199-200. PubMed ID: 17410510
[TBL] [Abstract][Full Text] [Related]
24. Endothelial neoplasms of the lungs.
Papla B
Pol J Pathol; 2008; 59(2):73-83. PubMed ID: 18669172
[TBL] [Abstract][Full Text] [Related]
25. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.
Detoraki A; Staiano RI; Granata F; Giannattasio G; Prevete N; de Paulis A; Ribatti D; Genovese A; Triggiani M; Marone G
J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Tie2 receptor antagonism in angiosarcoma.
Hasenstein JR; Kasmerchak K; Buehler D; Hafez GR; Cleary K; Moody JS; Kozak KR
Neoplasia; 2012 Feb; 14(2):131-40. PubMed ID: 22431921
[TBL] [Abstract][Full Text] [Related]
28. [Pulmonary epithelioid hemangioendothelioma: report of a case].
Zhao HF; He CN; Li P; Zhai JP; Zhang XZ
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):277. PubMed ID: 20654132
[No Abstract] [Full Text] [Related]
29. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
[TBL] [Abstract][Full Text] [Related]
30. [Primary pulmonary soft tissue sarcoma].
Teng XD; Kong M
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):204-8. PubMed ID: 22800492
[No Abstract] [Full Text] [Related]
31. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
[TBL] [Abstract][Full Text] [Related]
32. Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: a comparison study by immunofluorescence.
Man XY; Yang XH; Cai SQ; Bu ZY; Wu XJ; Lu ZF; Zheng M
Clin Exp Dermatol; 2009 Apr; 34(3):396-401. PubMed ID: 19309374
[TBL] [Abstract][Full Text] [Related]
33. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.
Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T
Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386
[TBL] [Abstract][Full Text] [Related]
34. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
35. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
Horta BA; Sodero AC; de Alencastro RB
J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer.
Ming J; Zhang Q; Qiu X; Wang E
Eur J Cancer; 2009 Mar; 45(5):866-73. PubMed ID: 19136250
[TBL] [Abstract][Full Text] [Related]
37. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
38. [Epitheliod hemangioendothelioma of the lung].
Mukhina MS; Maksimova NA; Tarasova MV; Levchenko IuA; Kulakova IuA; Romanchishin AF
Arkh Patol; 2009; 71(6):39-41. PubMed ID: 20131506
[TBL] [Abstract][Full Text] [Related]
39. Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer.
Nakanishi R; Oka N; Nakatsuji H; Koizumi T; Sakaki M; Takahashi M; Fukumori T; Kanayama HO
Urol Int; 2009; 83(1):98-106. PubMed ID: 19641368
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
